Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2012
Date:5/8/2012

ata at the American Society of Clinical Oncology showing that treatment with OGX-427 produced a trend toward increased tumor cell death in patients with bladder cancer and preliminary Phase 2 data showing that treatment with OGX-427 decreased prostate specific antigen in patients with metastatic prostate cancer.
  • Xenon Pharmaceuticals selected a drug targeting the hepcidin-hemojuvelin pathway as a development candidate to treat anemia of inflammation, a common form of anemia.
  • Conference Call
    At 4:30 p.m. Eastern Time today, May 8, Isis will conduct a live webcast conference call to discuss this earnings release and related activities.  Interested parties may listen to the call by dialing 866-831-6162 and refer to passcode "ISIS 2012," or access the webcast at www.isispharm.com.  A webcast replay will be available for a limited time at the same address.

    About Isis Pharmaceuticals, Inc.
    Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 26 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

    Forward Looking Statements
    This press release includes forward-looking statements regarding Isis Pharmaceuticals' financial position and outlook, Isis' business, and the therapeutic and commercial potential of Isis' technologies and products in development, including the business of Regulus, Isis' jointly owned subsidiary.
    '/>"/>

    SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Vanda Pharmaceuticals Reports First Quarter 2012 Results
    2. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
    3. Halozyme Reports First Quarter 2012 Financial Results
    4. MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
    5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
    6. IRIDEX Reports 2012 First Quarter Results
    7. Cambrex Reports First Quarter 2012 Results
    8. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
    9. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
    10. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
    11. Neuland Labs Reports Financial Results For Fiscal Year 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... --  Decision Resources Group finds that the sports ... will continue to be hindered in the near term ... longer timeline, however, the outlook is improved. Expanding populations ... the prevalence of osteoarthritic damage and sports-related injuries that ... solutions. Coupled with continuing economic recovery across ...
    (Date:7/29/2015)... , July 29, 2015  PDL BioPharma, Inc. ... entered into a revenue interest assignment agreement (the "Agreement") ... Inc. (NASDAQ: ARIA ) with up to $200 ... on the net revenues of Iclusig ® (ponatinib).  ... in two tranches of $50 million each, with the ...
    (Date:7/29/2015)... MELVILLE, N.Y., July 29, 2015  Henry Schein, ... provider of health care products and services to ... reported record second quarter financial results. ... 2015 were $2.6 billion, an increase of 0.5% ... consisted of 7.5% growth in local currencies and ...
    Breaking Medicine Technology:The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 3PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 2PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 3PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 4PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals 5Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25
    ... Calif., Oct. 13 Luminous Medical, Inc. announced today ... of electrochemical sensors for exclusive rights to incorporate its ... Luminous is developing its monitor to enable clinicians to ... , Previously, Luminous was planning to use a sensing ...
    ... , NEWNAN, Ga., Oct. 13 CeloNova BioSciences, ... body, the British Standards Institution, to expand the ... may be used and to add a tenth ... http://www.newscom.com/cgi-bin/prnh/20081001/CLW080LOGO-b ) , (Photo: ...
    Cached Medicine Technology:Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor 2Minimally Invasive Device Approved to Treat Liver Cancer, Fibroids, Tumors, and Bleeding 2Minimally Invasive Device Approved to Treat Liver Cancer, Fibroids, Tumors, and Bleeding 3
    (Date:7/29/2015)... , ... July 29, 2015 , ... Today marks a ... which invests in women-led, growth companies and is led by a group of experienced ... responded positively, and voted with their dollars to be a part of the fund. ...
    (Date:7/29/2015)... ... ... is National UV Awareness Month, and in honor of this month, Dr. Melda Isaac of ... from the sun, as well as how to best treat existing sun damage. Sun damage ... skin conditions in America. Many people do not protect their skin sufficiently when going out ...
    (Date:7/29/2015)... ... July 29, 2015 , ... Stealth Therapeutics Inc. ... Performance Study for the Invisiport at Wheaton Franciscan Healthcare in Milwaukee, Wis. The ... a less invasive, patient-friendly alternative to traditional chest ports and peripherally inserted central ...
    (Date:7/29/2015)... , ... July 29, 2015 , ... ... “forward thinker.” Since the late 1970s, Dr. Cottrell has been making predictions about ... The New Earth, documents many of these prognostications. He warns that extreme weather ...
    (Date:7/29/2015)... ... July 29, 2015 , ... HealthPostures ( ... a partnership with 247Ergo, an ergonomics specialty firm. Purpose of the partnership is ... the companies undertake could improve worker mobility, functionality and fitness levels. , ...
    Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3
    ... ... medical bills benefit from working with a medical billing advocate who helps ... medical care providers. Industry experts estimate that as many as 9 ... by insurance plans. Because unpaid medical bills are a leading cause ...
    ... ... ... ... ...
    ... ... ... ... ...
    ... ... ... , ... ...
    ... press release is available in French . ... Laval Centre de sant et de services sociaux, Universit de ... of greater collaboration between family physicians and community pharmacists for ... Canadian Medical Association Journal , the research project focused ...
    ... The gene for a newly recognized disease has been ... and the clinical skills and persistence of Indiana University ... physicians and researchers at the Clinic for Special Children ... the Amish. The identification of the new ...
    Cached Medicine News:Health News:AttackMedicalBills.com Fights Medical Bill And Health Insurance Processing Errors For Consumers 2Health News:AttackMedicalBills.com Fights Medical Bill And Health Insurance Processing Errors For Consumers 3Health News:Patheon Announces Date of First Quarter 2010 Financial Results and Conference Call 2Health News:Patheon Announces Date of First Quarter 2010 Financial Results and Conference Call 3Health News:Patheon Announces Date of First Quarter 2010 Financial Results and Conference Call 4Health News:Want to Live a Healthier Lifestyle? Now There's an App for That, Too! 2Health News:Want to Live a Healthier Lifestyle? Now There's an App for That, Too! 3Health News:Want to Live a Healthier Lifestyle? Now There's an App for That, Too! 4Health News:Want to Live a Healthier Lifestyle? Now There's an App for That, Too! 5Health News:Americans Want Uncle Sam's Help Putting Healthy Foods on Their Dinner Table 2Health News:Americans Want Uncle Sam's Help Putting Healthy Foods on Their Dinner Table 3Health News:Americans Want Uncle Sam's Help Putting Healthy Foods on Their Dinner Table 4Health News:Americans Want Uncle Sam's Help Putting Healthy Foods on Their Dinner Table 5Health News:Americans Want Uncle Sam's Help Putting Healthy Foods on Their Dinner Table 6Health News:'Improved doctor-pharmacist collaboration needed': study 2Health News:'Improved doctor-pharmacist collaboration needed': study 3Health News:Gene discovered for newly recognized disease in Amish children 2
    With a high lens and filter range this ophthalmoscope is ideal for the Primary Care Specialist...
    ... Convenient hand held quick and ... which is measured on the ... exophoria are measured by the ... be assessed by moving the ...
    ... all important missions, require dependable ... to your destination. The VIKING ... dependability. So you can set ... and not have to think ...
    The FLEXI-CUT Directional Debulking System is Abbott Vascular's latest atherectomy catheter designed to enhance performance and ease-of-use....
    Medicine Products: